Martin Colin John, Abuhaimed Abdullah
Clinical Physics and Bioengineering, University of Glasgow, Gartnavel Royal Hospital, Glasgow, G12 0XH, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.
King Abdulaziz City for Science And Technology, The National Center for Applied Physics, Riyadh, Al Riyadh Province, 11442, SAUDI ARABIA.
Phys Med Biol. 2024 Dec 12. doi: 10.1088/1361-6560/ad9e68.
Effective dose was created as a radiological protection dose quantity linked to risk to enable planning of radiological protection for the control of exposure. Its application and use has evolved from occupational and public exposure during work with radiation sources to medicine and applications in patient dosimetry. Effective dose is the sum of doses to organs and tissues within the body weighted according to their sensitivity to radiation for induction of stochastic effects determined from epidemiological studies of exposed populations. It is based on radiation risks averaged over the population and formulated using reference phantoms. Effective dose has been adopted by the medical community for application to patients and has been instrumental in raisingawareness of doses from medical imaging. However, although effective dose can beused for comparison of doses from different medical procedures, it is not designed forapplication to individual patients. The reasons being that organ doses vary with the stature of the patient and the radiation risks depend on the age and sex of the patient. Moves to more personalised medicine have created a desire for a more individualised approach to patient dosimetry, although support for this progression is not universal. This paper traces the evolution of effective dose and its applications. It reflects on how well effective dose provides a measure of risk for individual patients and examines ways in which a more personalised approach might be developed with reference to computed tomography (CT). It considers differences in dose relating to the sizes of patients and looks at variations in risks of cancer incidence within a population with an age distribution typical of patients and examines how this relates to the risk profile. Possible options for improving the individualisation of dosimetry are discussed.
.
有效剂量作为一种与风险相关的放射防护剂量量值而创建,用于为控制照射的放射防护规划提供依据。其应用范围已从辐射源工作期间的职业照射和公众照射扩展到医学领域以及患者剂量测定中的应用。有效剂量是体内各器官和组织所受剂量的总和,这些剂量根据它们对辐射诱发随机效应的敏感性进行加权,该敏感性由对受照人群的流行病学研究确定。它基于整个人口中的平均辐射风险,并使用参考人体模型来制定。有效剂量已被医学界采用,用于患者并有助于提高对医学成像剂量的认识。然而,尽管有效剂量可用于比较不同医疗程序的剂量,但它并非设计用于个体患者。原因在于器官剂量随患者身材而变化,且辐射风险取决于患者的年龄和性别。向更个性化医疗的转变引发了对更个体化患者剂量测定方法的需求,尽管对此进展的支持并不普遍。本文追溯了有效剂量及其应用的演变。它反思了有效剂量在多大程度上为个体患者提供了风险度量,并参考计算机断层扫描(CT)研究了如何开发更个性化方法的途径。它考虑了与患者体型相关的剂量差异,并研究了具有典型患者年龄分布的人群中癌症发病率风险的变化情况,并探讨了这与风险概况的关系。讨论了改进剂量测定个性化的可能选项。